Breast implant associated anaplastic large cell lymphoma: Evidence for an efficient diagnostic workup.

ABSTRACT:

Introduction

During the last few years it has been shown that an anaplastic T cell lymphoma can develop as a rare and late sequelae of implant-based breast reconstruction. This malignancy was recognized in the 2017 by WHO and named breast implant associated anaplastic large T cell lymphoma (BIA-ALCL). BIA-ALCL usually presents as abundant effusion around the implant, thus, in addition to cytology smears, its diagnosis also requires immunohistochemistry, T cells clonality and cytometry. Due to the increasing attention of clinicians, it is likely that the number of the BIA-ALCL suspected cases will grow in the future, implying the necessity of a reliable and cost-effective diagnostic procedure.

Methods

To achieve this goal, we retrospectively analyzed the results of laboratory

SUBMITTER: Vittoria L 

PROVIDER: S-EPMC10540484 | biostudies-literature | 2023 Oct

REPOSITORIES: biostudies-literature